Daiichi Sankyo said the appointment of a new chief executive for Ranbaxy Laboratories will strengthen the Japanese drug maker's control over its Indian subsidiary's management.
more
Monday, May 25, 2009
Subscribe to:
Post Comments (Atom)
The lastest news and observations about doing business in Asia.
No comments:
Post a Comment